Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990) Financial Statements

2 Followers

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Financial Overview

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H's market cap is currently HK$94.97B. The company's EPS TTM is HK$-0.2528; its P/E ratio is -199.25; Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is HK$0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 2.06B	$ 1.93B	$ 1.54B	$ 803.93M	$ 4.99M
Gross Profit	$ 1.48B	$ 1.27B	$ 759.18M	$ 527.11M	$ 1.78M
Operating Income	$ -466.19M	$ -211.40M	$ -452.61M	$ -393.93M	$ -125.48M
EBITDA	$ -249.23M	$ -47.36M	$ -308.31M	$ -351.19M	$ -121.94M
Net Income	$ -381.97M	$ -266.77M	$ -574.13M	$ -616.10M	$ -137.49M
Balance Sheet
Cash & Short-Term Investments	$ 4.56B	$ 3.08B	$ 2.53B	$ 119.22M	$ 15.76M
Total Assets	$ 5.99B	$ 4.27B	$ 3.51B	$ 993.14M	$ 156.61M
Total Debt	$ 88.44M	$ 126.75M	$ 59.92M	$ 3.01B	$ 460.59M
Net Debt	$ -3.24B	$ -1.22B	$ -1.51B	$ 2.90B	$ 444.84M
Total Liabilities	$ 1.12B	$ 959.34M	$ 1.18B	$ 4.22B	$ 665.95M
Stockholders' Equity	$ 4.87B	$ 3.31B	$ 2.33B	$ -3.23B	$ -509.33M
Cash Flow
Free Cash Flow	$ -306.55M	$ -510.89M	$ -22.69M	$ -309.84M	$ -95.78M
Operating Cash Flow	$ -180.30M	$ -429.77M	$ 59.56M	$ -270.85M	$ -81.24M
Investing Cash Flow	$ 411.01M	$ -822.00M	$ -1.03B	$ -32.15M	$ -14.58M
Financing Cash Flow	$ 1.73B	$ 1.04B	$ 2.38B	$ 313.45M	$ 106.18M

Currency in USD

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Debt to Assets

Balance Sheet >

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Cash Flow

Cash Flow >

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >